Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 114
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Worldwide (Iberdomide, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Orange, California
  • +270 more
Apr 11, 2023

Multiple Myeloma, Relapse Multiple Myeloma Trial in Chicago (Belantamab mafodotin, Carfilzomib, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Relapse Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Chicago, Illinois
    University of Chicago Medicine Comprehensive Cancer Center
Mar 23, 2023

Multiple Myeloma Trial in Spain, United States (BB2121, CC-220, BMS-986405)

Recruiting
  • Multiple Myeloma
  • BB2121
  • +2 more
  • Birmingham, Alabama
  • +33 more
Jan 26, 2023

Multiple Myeloma Trial in United States (Lenalidomide, Daratumumab/rHuPH20)

Recruiting
  • Multiple Myeloma
  • Anchorage, Alaska
  • +698 more
Jan 24, 2023

Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Birmingham, Alabama
  • +60 more
Jan 24, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab, Lenalidomide, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Little Rock, Arkansas
  • +145 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab IV, Lenalidomide, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Daratumumab IV
  • +3 more
  • Birmingham, Alabama
  • +211 more
Jan 17, 2023

Multiple Myeloma Trial in France, Spain, United States (Daratumumab, Velcade, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Duarte, California
  • +21 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Placebo, Ixazomib)

Completed
Has Results
  • Multiple Myeloma
  • Fountain Valley, California
  • +274 more
Jan 13, 2023

Multiple Myeloma Trial in Worldwide (CC-220, Dexamethasone, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +126 more
Jan 10, 2023

Multiple Myeloma Trial in Worldwide (bb2121, Daratumumab, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +8 more
  • Birmingham, Alabama
  • +59 more
Dec 13, 2022

Multiple Myeloma Trial in Worldwide (Pomalidomide, Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Mobile, Alabama
  • +278 more
Dec 6, 2022

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Birmingham, Alabama
  • +125 more
Nov 21, 2022

Multiple Myeloma Trial in Japan, United States (JNJ-68284528)

Completed
  • Multiple Myeloma
  • JNJ-68284528
  • Phoenix, Arizona
  • +20 more
Oct 5, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab (PF-06863135))

Active, not recruiting
  • Multiple Myeloma
  • Elranatamab (PF-06863135)
  • Beverly Hills, California
  • +75 more
Oct 4, 2022

Multiple Myeloma Trial in Worldwide (Cilta-cel)

Recruiting
  • Multiple Myeloma
  • Phoenix, Arizona
  • +30 more
Aug 11, 2022

Multiple Myeloma Trial in United States (Cilta-cel, Lymphodepleting Therapy (Cyclophosphamide and Fludarabine))

Recruiting
  • Multiple Myeloma
  • Cilta-cel
  • Lymphodepleting Therapy (Cyclophosphamide and Fludarabine)
  • Duarte, California
  • +23 more
Aug 1, 2022

Multiple Myeloma Trial in Chicago, Boston, Milwaukee (PHE885)

Recruiting
  • Multiple Myeloma
  • PHE885
  • Chicago, Illinois
  • +4 more
Jul 28, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin frozen liquid, Belantamab mafodotin lyophilized powder)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
Jul 27, 2022

Multiple Myeloma Trial in Greece, Korea, Republic of, United States (Belantamab mafodotin)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • Tucson, Arizona
  • +21 more
Jul 20, 2022

NSCLC, Ovarian Cancer, Fallopian Tube Cancer Trial in United States (CART-TnMUC1, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +5 more
  • CART-TnMUC1
  • +2 more
  • Phoenix, Arizona
  • +9 more
Jul 18, 2022

Multiple Myeloma Trial in Worldwide (CTX120)

Active, not recruiting
  • Multiple Myeloma
  • CTX120
  • Chicago, Illinois
  • +9 more
Jul 14, 2022

Multiple Myeloma Trial in Canada, United States (PF-06863135 monotherapy IV or SC, PF-06863135 + dexamethasone, PF-06863135 +

Active, not recruiting
  • Multiple Myeloma
  • PF-06863135 monotherapy IV or SC
  • +3 more
  • Encinitas, California
  • +37 more
Jul 7, 2022

Multiple Myeloma Trial in Worldwide (BL-8040 1.25mg/kg + G-CSF, Placebo +G-CSF)

Active, not recruiting
  • Multiple Myeloma
  • BL-8040 1.25mg/kg + G-CSF
  • Placebo +G-CSF
  • Los Angeles, California
  • +17 more
Jun 14, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Durvalumab, Pomalidomide)

Completed
  • Multiple Myeloma
  • Duarte, California
  • +43 more
Jun 9, 2022